Styrene maleic acid-encapsulated paclitaxel micelles: antitumor activity and toxicity studies following oral administration in a murine orthotopic colon cancer model

References

• YamanakaYJLeongKWEngineering strategies to enhance nanoparticle-mediated oral deliveryJ Biomater Sci Polym Ed200819121549157019017470
   PubMed Web of Science ®Google Scholar
• SinglaAKGargAAggarwalDPaclitaxel and its formulationsInt J Pharm20022351–217919211879753
   PubMed Web of Science ®Google Scholar
• EinzigAINeubergDWiernikPHPhase II trial of paclitaxel in patients with advanced colon cancer previously untreated with cytotoxic chemotherapy: an eastern cooperative oncology group trial (PA286)Am J Ther199631175075411862233
   PubMedGoogle Scholar
• SwantonCTomlinsonIDownwardJChromosomal instability, colorectal cancer and taxane resistanceCell Cycle20065881882316628000
   PubMed Web of Science ®Google Scholar
• MullinJMLaughlinKVGinanniNMaranoCWClarkeHMPeralta SolerAIncreased tight junction permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancersAnn N Y Acad Sci2000915123123611193580
   PubMedGoogle Scholar
• SolerAPMillerRDLaughlinKVCarpNZKlurfeldDMMullinJMIncreased tight junctional permeability is associated with the development of colon cancerCarcinogenesis19992081425143210426787
   PubMed Web of Science ®Google Scholar
• WoodAJRowinskyEKDonehowerRCPaclitaxel (taxol)N Engl J Med199533215100410147885406
   PubMed Web of Science ®Google Scholar
• MalingréMMTerwogtJMMBeijnenJHPhase I and pharmacokinetic study of oral paclitaxelJ Clin Oncol200018122468247510856107
   PubMed Web of Science ®Google Scholar
• DeMarioMDRatainMJOral chemotherapy: rationale and future directionsJ Clin Oncol1998167255725679667278
   PubMed Web of Science ®Google Scholar
• ThankiKGangwalRPSangamwarATJainSOral delivery of anticancer drugs: challenges and opportunitiesJ Control Release20131701154023648832
   PubMed Web of Science ®Google Scholar
• PeltierSOgerJ-MLagarceFCouetWBenoîtJ-PEnhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsulesPharm Res20062361243125016715372
   PubMed Web of Science ®Google Scholar
• FangJNakamuraHMaedaHThe EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effectAdv Drug Deliv Rev201163313615120441782
   PubMed Web of Science ®Google Scholar
• ZhaoJLiuJWeiTQuercetin-loaded nanomicelles to circumvent human castration-resistant prostate cancer in vitro and in vivoNanoscale2016895126513826875690
   PubMedGoogle Scholar
• IwaiKMaedaHKonnoTUse of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray imageCancer Res1984445211521216324996
   PubMed Web of Science ®Google Scholar
• LeuAJBerkDALymboussakiAAlitaloKJainRKAbsence of functional lymphatics within a murine sarcoma: a molecular and functional evaluationCancer Res200060164324432710969769
   PubMed Web of Science ®Google Scholar
• ParayathNNNehoffHMüllerPTaurinSGreishKStyrene maleic acid micelles as a nanocarrier system for oral anticancer drug delivery–dual uptake through enterocytes and M-cellsInt J Nanomed2015104653
   PubMed Web of Science ®Google Scholar
• GreishKSawaTFangJAkaikeTMaedaHSMA–doxorubicin, a new polymeric micellar drug for effective targeting to solid tumoursJ Control Release200497221923015196749
   PubMed Web of Science ®Google Scholar
• VichaiVKirtikaraKSulforhodamine B colorimetric assay for cytotoxicity screeningNat Protoc2006131112111617406391
   PubMed Web of Science ®Google Scholar
• TsengWLeongXEnglemanEOrthotopic mouse model of colorectal cancerJ Vis Exp20071048418989400
   PubMedGoogle Scholar
• BaetenCIHillenFPauwelsPde BruineAPBaetenCGPrognostic role of vasculogenic mimicry in colorectal cancerDis Colon Rectum200952122028203519934926
   PubMed Web of Science ®Google Scholar
• AHC Academic Health Centre, University of Minnesota2011 Available from: http://www.ahc.umn.edu/rar.refvalues.htmlAccessed October 21, 2015
   Google Scholar
• MoynihanHCreanAPhysicochemical Basis of PharmaceuticalsNew YorkOxford University Press2009
   Google Scholar
• EisemanJEddingtonNLeslieJPlasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 miceCancer Chemother Pharmacol19943464654717923556
   PubMed Web of Science ®Google Scholar
• TaurinSNehoffHGreishKAnticancer nanomedicine and tumor vascular permeability; where is the missing link?J Control Release2012164326527522800576
   PubMed Web of Science ®Google Scholar
• RamasamyTRuttalaHBChoiJYEngineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecanChem Commun2015512657585761
   PubMed Web of Science ®Google Scholar
• RamasamyTKimJChoiHGYongCSKimJONovel dual drug-loaded block ionomer complex micelles for enhancing the efficacy of chemotherapy treatmentsJ Biomed Nanotechnol20141071304131224804551
   PubMed Web of Science ®Google Scholar
• RamasamyTKimJHChoiJYpH sensitive polyelectrolyte complex micelles for highly effective combination chemotherapyJ Mater Chem B201423763246333
   PubMed Web of Science ®Google Scholar
• PritchardTRosengrenRJGreishKTaurinSRaloxifene nanomicelles reduce the growth of castrate-resistant prostate cancerJ Drug Target201624544144926373825
   PubMed Web of Science ®Google Scholar
• LeeALVenkataramanSSiratSBGaoSHedrickJLYangYYThe use of cholesterol-containing biodegradable block copolymers to exploit hydrophobic interactions for the delivery of anticancer drugsBiomaterials20123361921192822137125
   PubMed Web of Science ®Google Scholar
• RowinskyEKOnettoNCanettaRArbuckSTaxol: the first of the taxanes, an important new class of antitumor agentsSeminars in Oncology19921966466621361079
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• DickinsonEEttelaieRKostakisTMurrayBSFactors controlling the formation and stability of air bubbles stabilized by partially hydrophobic silica nanoparticlesLangmuir200420208517852515379469
   PubMedGoogle Scholar
• JaniPHalbertGWLangeidgeJFlorenceATNanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependencyJ Pharm Pharmacol199042128218261983142
   PubMed Web of Science ®Google Scholar
• MathiowitzEJacobJSJongYSBiologically erodable microspheres as potential oral drug delivery systemsNature199738666234104149121559
   PubMed Web of Science ®Google Scholar
• IyerAKGreishKFangJMurakamiRMaedaHHigh-loading nanosized micelles of copoly(styrene–maleic acid)–zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitorBiomaterials200728101871188117208294
   PubMedGoogle Scholar
• HörterDDressmanJInfluence of physicochemical properties on dissolution of drugs in the gastrointestinal tractAdv Drug Deliv Rev2001461758711259834
   PubMedGoogle Scholar
• YaoH-JJuR-JWangX-XThe antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral deliveryBiomaterials201132123285330221306774
   PubMed Web of Science ®Google Scholar
• JainSPatilSRSwarnakarNKAgrawalAKOral delivery of doxorubicin using novel polyelectrolyte-stabilized liposomes (layersomes)Mol Pharm2012992626263522871060
   PubMed Web of Science ®Google Scholar
• DeryckeASde WittePALiposomes for photodynamic therapyAdv Drug Deliv Rev2004561173014706443
   PubMed Web of Science ®Google Scholar
• IwanagaKOnoSNariokaKOral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tractInt J Pharm199715717380
   Web of Science ®Google Scholar
• TaurinSNehoffHvan AswegenTRosengrenRJGreishKA novel role for raloxifene nanomicelles in management of castrate resistant prostate cancerBiomed Res Int20142014201432359424689036
   PubMedGoogle Scholar
• MüllerBPolymeric corrosion inhibitors for aluminium pigmentReact Funct Polym1999392165177
   Google Scholar
• BelottiDRieppiMNicolettiMIPaclitaxel (Taxol (R)) inhibits motility of paclitaxel-resistant human ovarian carcinoma cellsClin Cancer Res1996210172517309816123
   PubMedGoogle Scholar
• MyoungHHongS-DKimY-YHongS-PKimM-JEvaluation of the anti-tumor and anti-angiogenic effect of paclitaxel and thalidomide on the xenotransplanted oral squamous cell carcinomaCancer Lett2001163219120011165754
   PubMed Web of Science ®Google Scholar
• WangSXiangJLiZA plasma microRNA panel for early detection of colorectal cancerInt J Cancer2015136115216123456911
   PubMed Web of Science ®Google Scholar
• LiuZSunBQiLLiHGaoJLengXZinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transitionCancer Sci2012103481382022212097
   PubMed Web of Science ®Google Scholar
• CastleJCLoewerMBoegelSImmunomic, genomic and transcriptomic characterization of CT26 colorectal carcinomaBMC Genomics201415119024621249
   PubMedGoogle Scholar
• YangX-YLiY-XLiMZhangLFengL-XZhangNHyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancerCancer Lett2013334233834522776563
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [homepage on the Internet] Available from: ClinicalTrials.govAccessed October 26, 2015
   Google Scholar
• YangF-HZhangQLiangQ-YBioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micellesMolecules20152034337435625756651
   PubMed Web of Science ®Google Scholar
• NIH [webpage on the Internet]livertox.nih2015 Available from: http://livertox.nih.gov/Severity.htmlAccessed October 26, 2015
   Google Scholar
• HeathEILoRussoPRamalingamSSA phase 1 study of BMS-275183, a novel oral analogue of paclitaxel given on a daily schedule to patients with advanced malignanciesInvest New Drugs20112961426143120680660
   PubMedGoogle Scholar